Stoke Therapeutics, Inc. (STOK) - Stock Analysis
https://stockanalysis.com/stocks/stok/
Web6 days ago · Overview. Financials. Statistics. Forecast. Profile. Chart. 1D. 5D. 1M. YTD. 1Y. 5Y. Max. 5.18% ( 1D) About STOK. Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops medicines to treat the underlying causes of severe genetic diseases in the United States.
DA: 98 PA: 66 MOZ Rank: 22